Abercrombie & Fitch (ANF) 10-Q 7 Dec 20 2020 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2020	Dec. 02, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2020
Document Transition Report	false
Entity File Number	001-12107
Entity Registrant Name	Abercrombie & Fitch Co.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-1469076
Entity Address, Address Line One	6301 Fitch Path,
Entity Address, City or Town	New Albany,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43054
City Area Code	(614)
Local Phone Number	283-6500
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	ANF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		62,390,672
Entity Central Index Key	0001018840
Current Fiscal Year End Date	--01-30
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 31, 2020		Nov. 02, 2019	Oct. 31, 2020		Nov. 02, 2019
Document Period End Date				Oct. 31, 2020
Net sales	$ 819,653		$ 863,472	$ 2,003,340		$ 2,438,522
Cost of sales, exclusive of depreciation and amortization	295,220		344,541	791,154		976,868
Gross profit	524,433		518,931	1,212,186		1,461,654
Stores and distribution expense	346,263		377,697	978,757		1,110,656
Marketing, general and administrative expense	121,000		114,075	326,509		341,716
Flagship store exit (benefits) charges	(8,063)		285	(12,490)		47,023
Asset impairment, exclusive of flagship store exit charges	6,329		12,610	57,340		14,987
Other operating loss (income), net	288		(215)	(1,562)		(465)
Operating income (loss)	58,616		14,479	(136,368)		(52,263)
Interest expense, net	8,808		2,922	19,277		4,908
Income (loss) before income taxes	49,808		11,557	(155,645)		(57,171)
Income tax expense (benefit)	5,779		3,987	38,565		(16,931)
Net income (loss)	44,029		7,570	(194,210)		(40,240)
Less: Net income attributable to noncontrolling interests	1,758		1,047	2,203		3,534
Net income (loss) attributable to A&F	$ 42,271		$ 6,523	$ (196,413)		$ (43,774)
Net income (loss) per share attributable to A&F
Basic	$ 0.68		$ 0.10	$ (3.14)		$ (0.67)
Diluted	$ 0.66		$ 0.10	$ (3.14)		$ (0.67)
Weighted-average shares outstanding
Basic	62,558		63,099	62,541		64,932
Diluted	63,877		63,911	62,541		64,932
Other comprehensive (loss) income
Foreign currency translation, net of tax	$ 2,142		$ 1,355	$ 5,477		$ (5,219)
Derivative financial instruments, net of tax	(5,234)		(3,654)	1,224		(574)
Other comprehensive (loss) income	(3,092)	[1]	(2,299)	6,701	[1]	(5,793)
Comprehensive income (loss)	40,937		5,271	(187,509)		(46,033)
Less: Comprehensive income attributable to noncontrolling interests	1,758		1,047	2,203		3,534
Comprehensive income (loss) attributable to A&F	$ 39,179		$ 4,224	$ (189,712)		$ (49,567)
[1]	No tax effect was recognized during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020
Current assets:
Cash and equivalents	$ 812,881	$ 671,267
Receivables	89,074	80,251
Inventories	545,548	434,326
Other current assets	73,776	78,905
Total current assets	1,521,279	1,264,749
Property and equipment, net	593,932	665,290
Operating lease right-of-use assets	955,781	1,230,954
Other assets	205,970	388,672
Total assets	3,276,962	3,549,665
Current liabilities:
Accounts payable	334,775	219,919
Accrued expenses	356,370	302,214
Short-term portion of operating lease liabilities	255,775	282,829
Income taxes payable	6,663	10,392
Total current liabilities	953,583	815,354
Long-term liabilities:
Long-term portion of operating lease liabilities	1,010,051	1,252,634
Long-term portion of borrowings, net	343,559	231,963
Other liabilities	110,965	178,536
Total long-term liabilities	1,464,575	1,663,133
Stockholders’ equity
Class A Common Stock - $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented	1,033	1,033
Paid-in capital	396,505	404,983
Retained earnings	2,067,521	2,313,745
Accumulated other comprehensive loss, net of tax (“AOCL”)	(102,185)	(108,886)
Treasury stock, at average cost: 40,916 and 40,514 shares as of October 31, 2020 and February 1, 2020, respectively	(1,513,495)	(1,552,065)
Total Abercrombie & Fitch Co. stockholders’ equity	849,379	1,058,810
Noncontrolling interests	9,425	12,368
Total stockholders’ equity	858,804	1,071,178
Total liabilities and stockholders’ equity	$ 3,276,962	$ 3,549,665

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 31, 2020	Feb. 01, 2020
Stockholders’ equity
Treasury Stock, at Average Cost (in shares)	40,916,000	40,514,000
Class A Common Stock
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000,000	150,000,000
Class A Common Stock, shares issued	103,300,000	103,300,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019
Document Period End Date	Oct. 31, 2020
Operating activities
Net loss	$ (194,210)	$ (40,240)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation and amortization	127,248	124,910
Asset impairment		18,216
Loss on disposal	7,586	5,326
Provision for (benefit from) deferred income taxes	27,432	(20,631)
Share-based compensation	13,575	8,464
Changes in assets and liabilities:
Inventories	(109,665)	(154,791)
Accounts payable and accrued expenses	186,806	34,752
Operating lease right-of-use assets and liabilities	(41,976)	42,990
Income taxes	(7,168)	(2,264)
Other assets	30,403	(47,138)
Withdrawal from Rabbi Trust Assets	50,000	0
Other liabilities	11,523	(3,433)
Net cash provided by (used for) operating activities	158,894	(33,839)
Investing activities
Purchases of property and equipment	(91,748)	(154,373)
Net cash used for investing activities	(91,748)	(154,373)
Proceeds from Notes Payable	350,000	0
Financing activities
Purchase of treasury stock	(15,172)	(63,542)
Repayments of Short-term Debt	(210,000)	0
Repayment of borrowings under the senior secured asset-based revolving credit facility	(12,556)	(38,959)
Payments of Debt Issuance Costs	(7,151)	0
Proceeds from Short-term Debt	210,000	0
Repayments of Long-term Debt	(233,250)	(10,000)
Payment, Tax Withholding, Share-based Payment Arrangement	5,566	6,619
Other financing activities	(11,742)	(10,407)
Net cash provided by (used for) financing activities	70,129	(122,908)
Effect of foreign currency exchange rates on cash	2,269	(2,686)
Net increase (decrease) in cash and equivalents, and restricted cash and equivalents	139,544	(313,806)
Cash and equivalents, and restricted cash, beginning of period	692,264	745,829
Cash and equivalents, and restricted cash and equivalents, end of period	831,808	432,023
Supplemental information related to non-cash activities
Purchases of property and equipment not yet paid at end of period	26,554	36,951
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	(41,305)	293,281
Supplemental information related to cash activities
Cash paid for interest	9,182	12,022
Cash paid for income taxes	10,412	18,697
Cash received from income tax refunds	4,001	8,570
Cash paid for operating lease liabilities	$ 224,827	$ 311,275

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Equity Statement - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	AOCI Including Portion Attributable to Noncontrolling Interest [Member]	Treasury Stock [Member]
Shares, Outstanding		66,227					37,073
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	$ 405,379		$ 2,418,544	$ (102,452)	$ (1,513,604)
Noncontrolling interests				$ 9,721
Total stockholders' equity	$ 1,218,621
Income (Loss) Attributable to Noncontrolling Interest, before Tax				3,534
Net Income (Loss) Attributable to Parent	(43,774)				(43,774)
Net loss	(40,240)
Treasury Stock, Shares, Acquired		(3,957)					3,957
Treasury Stock, Value, Acquired, Cost Method	(63,542)						$ (63,542)
Dividends	(38,959)				(38,959)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		487					(487)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(6,619)		(13,862)		(16,496)		$ 23,739
Share-based compensation expense	(8,464)		(8,464)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(574)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(5,219)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(2,401)			(2,401)
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(75,165)
Shares, Outstanding		63,146					40,154
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	394,694		2,251,032	(105,946)	$ (1,548,836)
Noncontrolling interests				11,318
Total stockholders' equity	1,003,295
Income (Loss) Attributable to Noncontrolling Interest, before Tax				1,047
Net Income (Loss) Attributable to Parent	6,523				6,523
Net loss	7,570
Treasury Stock, Shares, Acquired		(412)					412
Treasury Stock, Value, Acquired, Cost Method	(5,730)						$ (5,730)
Dividends	(12,574)				(12,574)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		23					(23)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(181)		(509)		(831)		$ 1,159
Share-based compensation expense	(5,796)		(5,796)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(3,654)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	1,355
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(1,511)			(1,511)
Shares, Outstanding		62,757					40,543
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	399,981		2,244,150	(108,245)	$ (1,553,407)
Noncontrolling interests				10,854
Total stockholders' equity	994,366
Shares, Outstanding		62,786					40,514
Total Abercrombie & Fitch Co. stockholders’ equity	1,058,810	$ 1,033	404,983		2,313,745	(108,886)	$ (1,552,065)
Noncontrolling interests	12,368			12,368
Total stockholders' equity	1,071,178
Income (Loss) Attributable to Noncontrolling Interest, before Tax				2,203
Net Income (Loss) Attributable to Parent	(196,413)				(196,413)
Net loss	(194,210)
Treasury Stock, Shares, Acquired		(1,397)					1,397
Treasury Stock, Value, Acquired, Cost Method	(15,172)						$ (15,172)
Dividends	(12,556)				(12,556)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		995					(995)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(5,566)		(22,053)		(37,255)		$ 53,742
Share-based compensation expense	(13,575)		(13,575)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	1,224
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	5,477
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(5,146)			(5,146)
Shares, Outstanding		62,365					40,935
Total Abercrombie & Fitch Co. stockholders’ equity		$ 1,033	392,272		2,025,911	(99,093)	$ (1,514,442)
Noncontrolling interests				7,929
Total stockholders' equity	813,610
Income (Loss) Attributable to Noncontrolling Interest, before Tax				1,758
Net Income (Loss) Attributable to Parent	42,271				42,271
Net loss	44,029
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		19					(19)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(150)		(436)		(661)		$ 947
Share-based compensation expense	(4,669)		(4,669)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(5,234)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	2,142
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	(262)			(262)
Shares, Outstanding		62,384					40,916
Total Abercrombie & Fitch Co. stockholders’ equity	849,379	$ 1,033	$ 396,505		$ 2,067,521	$ (102,185)	$ (1,513,495)
Noncontrolling interests	9,425			$ 9,425
Total stockholders' equity	$ 858,804

Nature of Business (Notes)

Nature of Business (Notes)	9 Months Ended
	Oct. 31, 2020
Nature of Business [Abstract]
Nature of Business	Abercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a global multi-brand omnichannel specialty retailer, whose products are sold primarily through its Company-owned store and digital channels, as well as through various third-party wholesale, franchise and licensing arrangements. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids under the Hollister, Abercrombie & Fitch and abercrombie kids brands. The brands share a commitment to offering unique products of enduring quality and exceptional comfort that allow customers around the world to express their own individuality and style. The Company primarily has operations in North America, Europe and Asia, among other regions.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Significant Accounting Policies [Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with MAF’s portion of net income presented as net income attributable to noncontrolling interests (“NCI”) on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and MAF’s portion of equity presented as NCI on the Condensed Consolidated Balance Sheets. Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended Number of weeks Fiscal 2019 February 1, 2020 52 Fiscal 2020 January 30, 2021 52 Interim financial statements The Condensed Consolidated Financial Statements as of October 31, 2020, and for the thirteen and thirty-nine week periods ended October 31, 2020 and November 2, 2019, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2019 filed with the SEC on March 31, 2020. The February 1, 2020 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2020. Use of estimates The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. The extent to which the current outbreak of coronavirus disease (“COVID-19”) impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic and its impact on the length or frequency of store closures, and the extent to which COVID-19 will impact worldwide macroeconomic conditions including interest rates, the speed of the economic recovery, and governmental, business and consumer reactions to the pandemic. The Company’s assessment of these, as well as other factors, could impact management's estimates and result in material impacts to the Company’s consolidated financial statements in future reporting periods. Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location October 31, 2020 February 1, 2020 November 2, 2019 February 2, 2019 Cash and equivalents Cash and equivalents $ 812,881 $ 671,267 $ 410,775 $ 723,135 Long-term restricted cash and equivalents Other assets 14,633 18,696 18,698 22,694 Short-term restricted cash and equivalents Other current assets 4,294 2,301 2,550 — Cash and equivalents and restricted cash and equivalents $ 831,808 $ 692,264 $ 432,023 $ 745,829
BASIS OF PRESENTATION	Interim financial statements The Condensed Consolidated Financial Statements as of October 31, 2020, and for the thirteen and thirty-nine week periods ended October 31, 2020 and November 2, 2019, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2019 filed with the SEC on March 31, 2020. The February 1, 2020 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2020.

Impact of COVID-19 (Notes)

Impact of COVID-19 (Notes)	3 Months Ended
	Oct. 31, 2020
Unusual or Infrequent Item, or Both [Line Items]
Unusual or Infrequent Items, or Both, Disclosure [Text Block]	Recent developments The Company has seen, and may continue to see, material adverse impacts as a result of COVID-19. The extent of future impacts of COVID-19 on the Company’s business, including the duration and impact on overall customer demand, are uncertain as current circumstances are dynamic and depend on future developments, including, but not limited to, the duration and spread of COVID- 19 and the availability and acceptance of an effective vaccine or medical treatments. In January 2020, the Company began to experience business disruptions in the Asia-Pacific (“APAC”) region as a result of COVID-19. In February 2020, the situation escalated as the scope of COVID-19 worsened beyond the APAC region, with the United States (the “U.S.”) and the Europe, Middle East and Africa (“EMEA”) region experiencing significant outbreaks. In March 2020, the COVID-19 outbreak was declared to be a global pandemic by the World Health Organization. In response to COVID-19, certain governments have imposed travel restrictions and local statutory quarantines and the Company has recommended associates who are able to perform their role remotely continue to do so. The Company is reacting to COVID-19 on a daily basis, including by conforming to local government guidance and monitoring developments in government legislation or other government actions in response to the COVID-19 outbreak. The Company has also implemented a range of precautionary health and safety measures with the well-being of the Company’s customers, associates and business partners in mind. As a result of COVID-19, in January 2020, the Company temporarily closed the majority of its stores in the APAC region and in March 2020, the Company temporarily closed its stores across brands in North America and the EMEA region. The majority of APAC stores were reopened during March 2020, and the Company began to reopen stores in North America and the EMEA region on a rolling basis in late April 2020. As of October 31, 2020, approximately 97% of Company-operated stores had reopened for in-store service, although many with modified operating hours. The Company plans to follow the guidance of local governments to determine when it can reopen stores that have been closed due to COVID-19 and to evaluate whether further store closures will be necessary. The Company’s digital operations across brands have continued to serve the Company’s customers during this unprecedented period of temporary store closures as the Company’s distribution centers implemented enhanced cleaning and social distancing measures in order to remain operational. In response to elevated digital demand during this period, the Company has increased its omnichannel capabilities by continuing to offer Purchase-Online-Pickup-in-Store, including curbside pick-up at a majority of U.S. locations, and by utilizing ship-from-store capabilities. In addition, to prepare for the Fiscal 2020 holiday season, the Company has entered into a short-term lease for an additional distribution center and has partnered with incremental carriers. Impact of COVID-19 The Company has seen, and may continue to see, material reductions in sales across brands and regions as a result of COVID-19. Total net sales decreased approximately 5% and 18% for the thirteen and thirty-nine weeks ended October 31, 2020 as compared to the comparable periods ended November 2, 2019, respectively. The year-over-year decrease in total net sales was primarily driven by temporary widespread store closures and a decline in traffic as compared to the previous year as a result of COVID-19. The year-over-year decline in store sales was partially offset by digital sales growth of approximately 43% and 42% for the thirteen and thirty-nine weeks ended October 31, 2020 as compared to the comparable periods ended November 2, 2019, respectively. Primarily as a result of COVID-19 and the temporary closure of the Company’s stores, the Company recognized $14.8 million of charges to reduce the carrying value of inventory in cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) during the thirteen weeks ended May 2, 2020. During the thirty-nine weeks ended October 31, 2020, reductions in revenue have not been offset by proportional decreases in expense, as the Company continued to incur store occupancy costs such as operating lease costs, net of rent abatements agreed upon during the period, depreciation expense, and certain other costs such as compensation, net of government payroll relief, and administrative expenses resulting in a negative effect on the relationship between the Company’s costs and revenues. During this period, the Company suspended rent payments for a significant number of stores that were closed, and continues to engage with its landlords to find a mutually beneficial and agreeable path forward. The Company has elected to account for all qualifying lease concessions, those that are a direct consequence of COVID-19 and that result in revised lease consideration that is substantially the same or less than the original consideration, as if the enforceable rights and obligations associated with the concession existed in the original lease agreement. Rent abatements associated with such concessions are recognized in variable lease cost. Lease concessions granted as part of an agreement that substantially increases the total consideration as a result of the inclusion of additional terms, such as rent payments associated with a lease term extension, are treated as lease modifications. For stores where the Company suspended payments, the Company reclassified related amounts from operating lease liability to accrued expenses in the period during which rent was due, while continuing to recognize operating lease cost in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which among other things, provides refundable employee retention tax credits for wages paid to employees who are unable to work during the COVID-19 outbreak and the deferral of the employer–paid portion of social security taxes. Similar relief programs have also been established throughout the EMEA and APAC regions. Based on the Company's evaluation of the CARES Act and legislation across regions, the Company qualifies for certain payroll tax credits, and such government subsidies have been treated as offsets to the related operating expenses when recognized. During the thirteen and thirty-nine weeks ended October 31, 2020, the Company recognized qualified payroll tax credits reducing payroll expenses by approximately $2.8 million and $14.7 million, respectively, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), The Company intends to continue to defer qualified payroll and other tax payments as permitted by the CARES Act and other regional legislation. The Company also recognized asset impairment charges related to the Company’s right-of-use assets and property and equipment of $6.3 million and $57.3 million during the thirteen and thirty-nine weeks ended October 31, 2020, respectively, which were principally the result of the impact of COVID-19 on store cash flows. Refer to Note 9, “ ASSET IMPAIRMENT ,” for additional information. In addition, the Company has also experienced other material impacts as a result of COVID-19, such as deferred tax valuation allowances and other tax charges during the thirty-nine weeks ended October 31, 2020, adversely impacting results by $77.4 million. Refer to Note 11, “ INCOME TAXES ,” for additional information. Balance sheet, cash flow and liquidity During the thirty-nine weeks ended October 31, 2020, the Company has taken various actions to preserve liquidity and manage cash flows in order to best position the business for key stakeholders, including (i) partnering with merchandise and non-merchandise vendors in regards to payment terms; (ii) tightly managing inventory receipts to align inventory with expected market demand; (iii) significantly reducing expenses to better align operating costs with sales; and (iv) temporarily suspending its share repurchase program in March 2020 and its dividend program in May 2020. In addition, despite the Company's recent history of partnering with its vendors regarding payment terms, certain payment term extensions were temporary and certain previously deferred payments have since been made. There can be no assurance that the Company will be able to maintain extended payment terms or continue to defer payments, which may result in incremental operating cash outflows in future periods. As a precautionary measure in response to COVID-19, in March 2020, the Company borrowed $210.0 million under its senior secured asset-based revolving credit facility (the “ABL Facility”) to improve its near-term cash position and withdrew the majority of excess funds from the overfunded Rabbi Trust assets, providing the Company with $50.0 million of additional cash. In July 2020, the Company completed a private offering of $350.0 million aggregate principal amount of senior secured notes (the “Senior Secured Notes”) and used the net proceeds to repay all outstanding borrowings under the Company’s term loan facility (the “Term Loan Facility”), to repay a portion of the outstanding borrowings under the ABL Facility and to pay fees and expenses in connection with such repayments and the offering. Refer to Note 12, “ BORROWINGS ,” and Note 10, “ RABBI TRUST ASSETS ,” for additional information. As of October 31, 2020, the Company had liquidity of $1.158 billion as compared to $913.8 million as of February 1, 2020, comprised of cash and equivalents and actual incremental borrowing available to the Company under the ABL Facility.

Revenue Recognition (Notes)

Revenue Recognition (Notes)	9 Months Ended
	Oct. 31, 2020
Revenue Recognition [Abstract]
Revenue from Contract with Customer [Text Block]	Disaggregation of revenue All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). For information regarding the disaggregation of revenue, refer to Note 16, “ SEGMENT REPORTING . ” Contract liabilities The following table details certain contract liabilities representing unearned revenue as of October 31, 2020, February 1, 2020, November 2, 2019 and February 2, 2019: (in thousands) October 31, 2020 February 1, 2020 November 2, 2019 February 2, 2019 Gift card liability $ 22,910 $ 28,844 $ 19,855 $ 26,062 Loyalty program liability $ 19,640 $ 23,051 $ 21,396 $ 19,904 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Revenue associated with gift card redemptions and gift card breakage $ 11,717 $ 12,653 $ 32,792 $ 40,729 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs $ 9,686 $ 9,249 $ 23,377 $ 23,795

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
NET LOSS PER SHARE	Net income (loss) per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of Class A Common Stock (“Common Stock”). Additional information pertaining to net income (loss) per share attributable to A&F follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (40,742) (40,201) (40,759) (38,368) Weighted-average — basic shares 62,558 63,099 62,541 64,932 Dilutive effect of share-based compensation awards 1,319 812 — — Weighted-average — diluted shares 63,877 63,911 62,541 64,932 Anti-dilutive shares (1) 1,828 2,912 1,988 1,572 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value

Fair Value	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of October 31, 2020 and February 1, 2020 were as follows: Assets at Fair Value as of October 31, 2020 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 68,271 $ 43,596 $ — $ 111,867 Derivative instruments (2) — 461 — 461 Rabbi Trust assets (3) 1 60,418 — 60,419 Restricted cash equivalents (4) 6,670 7,918 — 14,588 Total assets $ 74,942 $ 112,393 $ — $ 187,335 Liabilities: Derivative instruments (2) $ — $ 367 $ — $ 367 Total liabilities $ — $ 367 $ — $ 367 Assets and Liabilities at Fair Value as of February 1, 2020 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 225 $ 58,447 $ — $ 58,672 Derivative instruments (2) — 1,969 — 1,969 Rabbi Trust assets (3) 1 109,048 — 109,049 Restricted cash equivalents (4) 9,765 4,601 — 14,366 Total assets $ 9,991 $ 174,065 $ — $ 184,056 Liabilities: Derivative instruments (2) $ — $ 1,460 $ — $ 1,460 Total liabilities $ — $ 1,460 $ — $ 1,460 (1) Level 1 assets consist of investments in money market funds. Level 2 assets consist of time deposits. (2) Level 2 assets and liabilities consist primarily of foreign currency exchange forward contracts. (3) Level 1 assets consist of investments in money market funds. Level 2 assets consist of trust-owned life insurance policies. (4) Level 1 assets consist of investments in U.S. treasury bills and money market funds. Level 2 assets consist of time deposits. The Company’s Level 2 assets and liabilities consist of: • Time deposits, which are valued at cost approximating fair value due to the short-term nature of these investments; • Trust-owned life insurance policies which are valued using the cash surrender value of the life insurance policies; and • Derivative instruments, primarily foreign currency exchange forward contracts, which are valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of long-term borrowings The Company’s borrowings under the Term Loan Facility and the Senior Secured Notes are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) October 31, 2020 February 1, 2020 Gross borrowings outstanding, carrying amount $ 350,000 $ 233,250 Gross borrowings outstanding, fair value $ 374,063 $ 233,979

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	Property and equipment, net consisted of: (in thousands) October 31, 2020 February 1, 2020 Property and equipment, at cost $ 2,741,167 $ 2,744,967 Less: Accumulated depreciation and amortization (2,147,235) (2,079,677) Property and equipment, net $ 593,932 $ 665,290 Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019.

Leases (Notes)

Leases (Notes)	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment. During thirty-nine weeks ended October 31, 2020, the Company suspended rent payments for a significant number of stores that were closed as a result of COVID-19, and continues to engage with its landlords to find a mutually beneficial and agreeable path forward. The Company has elected to account for all qualifying lease concessions, those that are a direct consequence of COVID-19 and that result in revised lease consideration that is substantially the same or less than the original consideration, as if the enforceable rights and obligations associated with the concession existed in the original lease agreement. Rent abatements associated with such concessions are recognized in variable lease cost. Lease concessions granted as part of an agreement that substantially increases the total consideration as a result of the inclusion of additional terms, such as rent payments associated with a lease term extension, are treated as lease modifications. For stores where the Company suspended payments, the Company reclassified related amounts from operating lease liability to accrued expenses in the period during which rent was due, while continuing to recognize operating lease cost in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). In addition, during the thirteen weeks ended October 31, 2020, the Company entered into a sublease agreement with a third party for the remaining lease term of one of its European Abercrombie & Fitch flagship store locations upon its expected closure during the thirteen weeks ending January 30, 2021. As of October 31, 2020, the Company's subleased property had a remaining lease term of 7.1 years with the sublease term from February 1, 2021 through November 30, 2027. The sublease arrangement provides for rent and occupancy related costs such as taxes, utilities and maintenance costs. Initial sublease terms provide for rent escalations based on the index under the lease, which were estimated upon initial measurement of the operating lease right-of-use asset and liability. The sublease agreement does not include residual value guarantees. Consistent with the Company's real estate leases, the sublease contains usage restrictions, but does not contain financial covenants and restrictions. Future minimum tenant operating lease payments remaining under this sublease as of October 31, 2020 were $29.0 million. The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Single lease cost (1) $ 83,743 $ 104,726 $ 264,932 $ 318,270 Variable lease cost (2) 14,428 25,990 61,763 129,073 Operating lease right-of-use asset impairment (3) 3,979 9,047 44,397 12,636 Total operating lease cost $ 102,150 $ 139,763 $ 371,092 $ 459,979 (1) Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as rent abatements related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. (3) Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. During the thirty-nine weeks ended October 31, 2020 and November 2, 2019, the Company paid $224.8 million and $311.3 million, respectively, for amounts included in the measurement of operating lease liabilities, net of rent abatements agreed upon during the period. These payments are included within operating activities on the Condensed Consolidated Statements of Cash Flows. As of October 31, 2020, the Company had minimum commitments related to additional operating lease contracts the terms of which have not yet commenced, primarily for its Company-operated retail stores, of approximately $3.3 million.

Asset Impairment (Notes)

Asset Impairment (Notes)	9 Months Ended
	Oct. 31, 2020
Asset Impairment [Abstract]
Asset Impairment [Text Block]	Asset impairment charges for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Operating lease right-of-use asset impairment (1) $ 3,979 $ 9,047 $ 44,397 $ 12,636 Property and equipment asset impairment 2,350 3,563 12,943 5,580 Total asset impairment $ 6,329 $ 12,610 $ 57,340 $ 18,216 (1) Includes $3.2 million of operating lease right-of-use asset impairment related to flagship store exit charges for each of the thirteen and thirty-nine weeks ended November 2, 2019. Refer to Note 17, “ FLAGSHIP STORE EXIT (BENEFITS) CHARGES .” Asset impairment charges for the thirteen and thirty-nine weeks ended October 31, 2020 were principally the result of the impact of COVID-19 and were related to certain of the Company’s stores across brands, geographies and store formats. The impairment charges for the thirty-nine weeks ended October 31, 2020 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $102.2 million, including $94.2 million related to operating lease right-of-use assets. Asset impairment charges for the thirteen weeks and thirty-nine weeks ended November 2, 2019, primarily related to certain of the Company’s international flagship stores. The impairment charges for the thirty-nine weeks ended November 2, 2019 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $36.8 million, including $32.3 million related to operating lease right-of-use assets.

Rabbi Trust Assets (Notes)

Rabbi Trust Assets (Notes)	9 Months Ended
	Oct. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	As a precautionary measure and to preserve liquidity in light of the circumstances surrounding COVID-19, during the thirty-nine weeks ended October 31, 2020, the Company withdrew the majority of excess funds from the overfunded Rabbi Trust assets, providing the Company with $50.0 million of additional cash. Investments of Rabbi Trust assets consisted of the following as of October 31, 2020 and February 1, 2020: (in thousands) October 31, 2020 February 1, 2020 Trust-owned life insurance policies (at cash surrender value) $ 60,418 $ 109,048 Money market funds 1 1 Rabbi Trust assets $ 60,419 $ 109,049 Realized gains resulting from the change in cash surrender value of the Rabbi Trust assets for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Realized gains related to Rabbi Trust assets $ 391 $ 805 $ 1,369 $ 2,394

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and is adjusted as necessary for discrete quarterly events. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings. Impact of valuation allowances and other tax charges during Fiscal 2020 The Company’s effective tax rate for the thirty-nine weeks ended October 31, 2020 was impacted by $77.4 million of adverse tax impacts, ultimately giving rise to income tax expense on a consolidated pre-tax year-to-date loss. Further details regarding these adverse tax impacts are as follows: • The Company anticipates pre-tax losses for the full fiscal year in certain jurisdictions, based on information currently available, primarily due to the significant adverse impacts of COVID-19. The Company did not recognize income tax benefits on $180.7 million of pre-tax losses during the thirty-nine weeks ended October 31, 2020, resulting in an adverse tax impact of $41.8 million. • The Company recognized charges of $35.6 million related to the establishment of valuation allowances and other tax charges in certain jurisdictions during the thirty-nine weeks ended October 31, 2020, principally as a result of the significant adverse impacts of COVID–19. These charges related to valuation allowances recognized by the Company of $10.6 million and $6.0 million related to the U.S. and Germany, respectively, as well as valuation allowances and other tax charges in certain other jurisdictions against underlying tax asset balances that existed as of February 1, 2020. The Company also recognized valuation allowances of $78.9 million related to Switzerland with a U.S. branch equally offsetting amount, which in net, did not have an impact on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). Changes in assumptions may occur based on new information that becomes available resulting in adjustments in the period in which a determination is made. Global legislation in response to COVID-19 In March 2020, the CARES Act was enacted into U.S. law, intended to provide economic relief to those impacted by COVID-19 and enhance business’ liquidity. The Company continues to examine impacts that the provisions of the CARES Act may have on U.S. income taxes; however, the Company does not currently expect that these provisions will have a material impact on its income taxes. The Company is still assessing the applicability of other recently passed global legislation, including the potential income tax measures offered in international jurisdictions where the Company’s operations have also been impacted by COVID-19. Share-based compensation Refer to Note 13, “ SHARE-BASED COMPENSATION ,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended November 2, 2019.

Borrowings

Borrowings	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Borrowings	Details on the Company’s long-term borrowings, net, as of October 31, 2020 and February 1, 2020 are as follows: (in thousands) October 31, 2020 February 1, 2020 Long-term portion of borrowings, gross at carrying amount $ 350,000 $ 233,250 Unamortized fees (6,441) (932) Unamortized discount — (355) Long-term borrowings, net $ 343,559 $ 231,963 Senior Secured Notes On July 2, 2020, Abercrombie & Fitch Management Co. (“A&F Management”), a wholly-owned indirect subsidiary of A&F, completed the private offering of the Senior Secured Notes, with $350 million aggregate principal amount due in 2025 at an offering price of 100% of the principal amount thereof. The Senior Secured Notes were issued pursuant to an indenture, dated as of July 2, 2020, by and among A&F Management, A&F and certain of its wholly-owned subsidiaries, as guarantors, and U.S. Bank National Association, as trustee, and as collateral agent. The Senior Secured Notes will mature on July 15, 2025 and bear interest at a rate of 8.75% per annum, with semi-annual interest payments beginning in January 2021. The Company used the net proceeds from the offering of the Senior Secured Notes to repay outstanding borrowings and accrued interest of $233.6 million and $110.8 million under the Term Loan Facility and the ABL Facility, respectively, with the remaining net proceeds used towards fees and expenses in connection with such repayments and the offering of the Senior Secured Notes. The Company recorded deferred financing fees associated with the issuance of the Senior Secured Notes, which are being amortized to interest expense over the contractual term of the Senior Secured Notes. ABL Facility The ABL Facility, which was entered into on August 7, 2014 through A&F Management as the lead borrower (with A&F and certain other subsidiaries of A&F as borrowers or guarantors) and later amended on October 19, 2017, provides for a senior secured asset-based revolving credit facility of up to $400 million (the “ABL Facility”). The ABL Facility will mature on October 19, 2022. As a precautionary measure and to improve the Company’s cash position in light of the circumstances surrounding COVID-19, during the thirteen weeks ended May 2, 2020, the Company borrowed $210.0 million under the ABL Facility. During the thirteen weeks ended August 1, 2020, the Company used a portion of the net proceeds from the offering of the Senior Secured Notes and cash on hand to repay all outstanding borrowings under the ABL Facility. The Company did not have any borrowings outstanding under the ABL Facility as of October 31, 2020 or as of February 1, 2020. As of October 31, 2020, the Company had availability under the ABL Facility of $383.7 million, net of $0.8 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $30 million under the ABL Facility, actual incremental borrowing available to the Company under the ABL Facility was $345.2 million as of October 31, 2020. The provisions under the credit agreement applicable to the ABL Facility have not changed from those described in Note 12, “BORROWINGS,” in the Notes to Consolidated Financial Statements contained in “ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA” of A&F’s Annual Report on Form 10-K for Fiscal 2019. Term Loan Facility The Term Loan Facility, which was entered into on August 7, 2014 through A&F Management as the lead borrower (with A&F and certain other subsidiaries of A&F as borrowers or guarantors) and later amended on June 22, 2018, provided for a term loan facility of $300 million. The Company had gross borrowings outstanding under the Term Loan Facility of $233.3 million as of February 1, 2020. During the thirteen weeks ended August 1, 2020, the Company used a portion of the proceeds from the issuance of the Senior Secured Notes to repay all outstanding borrowings under the Term Loan Facility and upon repayment the Term Loan Facility was terminated effective as of July 2, 2020. The Term Loan Facility was previously scheduled to mature on August 7, 2021. Representations, warranties and covenants The agreements related to the Senior Secured Notes and ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the Company’s or A&F Management’s assets to, another entity. The Senior Secured Notes are guaranteed on a senior secured basis, jointly and severally, by A&F and each of the existing and future wholly-owned domestic restricted subsidiaries of A&F that guarantee or will guarantee A&F Management’s ABL Facility or certain future capital markets indebtedness. Certain of the agreements related to the Senior Secured Notes and ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances. The Company was in compliance with all debt covenants under these agreements as of October 31, 2020.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	Financial statement impact The following table details share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Share-based compensation expense $ 4,669 $ 5,796 $ 13,575 $ 8,464 Income tax benefit associated with share-based compensation expense recognized (1) $ — $ 1,211 $ — $ 1,566 (1) No income tax benefit was recognized related to share-based compensation expense during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction. The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Income tax discrete benefits realized for tax deductions related to the issuance of shares (1) $ — $ 6 $ — $ 1,175 Income tax discrete charges realized upon cancellation of stock appreciation rights (1) — (447) — (611) Total income tax discrete (charges) benefits related to share-based compensation awards $ — $ (441) $ — $ 564 (1) No income tax benefits or charges related to these items were recognized during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction. The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Employee tax withheld upon issuance of shares (1) $ 150 $ 181 $ 5,566 $ 6,619 (1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows. Restricted stock units The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 31, 2020: Service-based Restricted Performance-based Restricted Market-based Restricted Number of (1) Weighted- Number of Weighted- Number of Weighted- Unvested at February 1, 2020 1,676,831 $ 18.68 747,056 $ 15.11 421,784 $ 23.05 Granted 2,280,194 8.57 — — 519,905 16.24 Adjustments for performance achievement — — 38,381 11.37 134,122 11.79 Vested (790,429) 17.42 (481,304) 9.63 (350,447) 11.79 Forfeited (107,795) 13.83 (6,917) 22.80 (3,485) 35.61 Unvested at October 31, 2020 (2) 3,058,801 $ 11.63 297,216 $ 22.43 721,879 $ 21.46 (1) Includes 66,624 unvested restricted stock units as of October 31, 2020, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year. (2) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Certain unvested shares related to restricted stock units with performance-based vesting conditions can be achieved at up to 200% of their target vesting amount. The following table details unrecognized compensation cost and the remaining weighted-average period these costs are expected to be recognized for restricted stock units as of October 31, 2020: (in thousands) Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost $ 27,879 $ — $ 9,939 Remaining weighted-average period cost is expected to be recognized (years) 1.3 0.0 1.1 Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: (in thousands) October 31, 2020 November 2, 2019 Service-based restricted stock units: Total grant date fair value of awards granted $ 19,541 $ 16,175 Total grant date fair value of awards vested $ 13,769 $ 13,087 Performance-based restricted stock units: Total grant date fair value of awards granted $ — $ 5,379 Total grant date fair value of awards vested $ 4,635 $ — Market-based restricted stock units: Total grant date fair value of awards granted $ 8,443 $ 4,176 Total grant date fair value of awards vested $ 4,132 $ 511 The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 31, 2020 and November 2, 2019, respectively, were as follows: October 31, 2020 November 2, 2019 Grant date market price $ 12.31 $ 25.34 Fair value $ 16.24 $ 36.24 Assumptions: Price volatility 67 % 57 % Expected term (years) 2.4 2.9 Risk-free interest rate 0.2 % 2.2 % Dividend yield — % 3.2 % Average volatility of peer companies 66.0 % 40.0 % Average correlation coefficient of peer companies 0.4967 0.2407 Stock appreciation rights The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 31, 2020: Number of Weighted-Average Aggregate Weighted-Average Outstanding at February 1, 2020 796,725 $ 40.06 Granted — — Exercised — — Forfeited or expired (382,225) 47.87 Outstanding at August 1, 2020 414,500 $ 32.86 $ — 3.2 Stock appreciation rights exercisable at October 31, 2020 414,500 $ 32.86 $ — 3.2 Stock appreciation rights expected to become exercisable in the future as of October 31, 2020 — $ — $ — 0.0 No stock appreciation rights were exercised during the thirty-nine weeks ended October 31, 2020. Additional information pertaining to stock appreciation rights for the thirty-nine weeks ended November 2, 2019 follows: (in thousands) November 2, 2019 Total grant date fair value of awards exercised $ 620

Derivative Instruments

Derivative Instruments	9 Months Ended
	Oct. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily foreign currency exchange forward contracts designated as cash flow hedges, to hedge the foreign currency exchange rate exposure associated with forecasted foreign currency denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign currency denominated intercompany receivables. Fluctuations in foreign currency exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. Dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These foreign currency exchange forward contracts typically have a maximum term of twelve months. The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in AOCL into earnings. The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in foreign currency exchange rates result in transaction gains or losses being recorded in earnings, as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of October 31, 2020, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 65,537 British pound $ 29,603 Canadian dollar $ 11,239 (1) Amount reported is the U.S. Dollar notional amount outstanding as of October 31, 2020. The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheet as of February 1, 2020 were as follows: (in thousands) Location October 31, 2020 February 1, 2020 Location October 31, 2020 February 1, 2020 Derivatives designated as cash flow hedging instruments Other current assets $ 461 $ 1,869 Accrued expenses $ 367 $ 1,377 Derivatives not designated as hedging instruments Other current assets — 100 Accrued expenses — 83 Total $ 461 $ 1,969 $ 367 $ 1,460 As a result of COVID-19, there was a significant change in the expected timing of previously hedged intercompany sales transactions, resulting in a dedesignation of the related hedge instruments. At the time of dedesignation of these hedges, they were in a net gain position of approximately $12.6 million. Due to the extenuating circumstances leading to dedesignation, gains associated with these hedges at the time of dedesignation are deferred in AOCL until being reclassified into cost of goods sold, exclusive of depreciation and amortization when the originally forecasted transactions occur and the hedged items affect earnings. During the thirty-nine weeks ended October 31, 2020, $11.1 million had been reclassified from AOCL into earnings. During the thirty-nine weeks ended October 31, 2020 and subsequent to the dedesignation of these hedges, these hedge contracts were settled. Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Gain (loss) recognized in AOCL (1) $ 93 $ (1,136) $ 12,328 $ 5,918 Gain reclassified from AOCL into cost of sales, exclusive of depreciation and amortization (2) $ 5,327 $ 2,541 $ 11,104 $ 6,845 (1) Amount represents the change in fair value of derivative contracts. (2) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 (Loss) gain recognized in other operating (income) loss, net $ — $ (1,023) $ 742 $ 157

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Oct. 31, 2020
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	r the thirteen and thirty-nine weeks ended October 31, 2020, the activity in AOCL was as follows: Thirteen Weeks Ended October 31, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) Other comprehensive income before reclassifications 2,142 93 2,235 Reclassified gain from accumulated other comprehensive loss (1) — (5,327) (5,327) Other comprehensive income (loss) after reclassifications (2) 2,142 (5,234) (3,092) Ending balance at October 31, 2020 $ (104,490) $ 2,305 $ (102,185) Thirty-nine Weeks Ended October 31, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 1, 2020 $ (109,967) $ 1,081 $ (108,886) Other comprehensive income before reclassifications 5,477 12,328 17,805 Reclassified gain from accumulated other comprehensive loss (1) — (11,104) (11,104) Other comprehensive income after reclassifications (2) 5,477 1,224 6,701 Ending balance at October 31, 2020 $ (104,490) $ 2,305 $ (102,185) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). (2) No tax effect was recognized during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction. For the thirteen and thirty-nine weeks ended November 2, 2019, the activity in AOCL was as follows: Thirteen Weeks Ended November 2, 2019 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 3, 2019 $ (111,461) $ 5,515 $ (105,946) Other comprehensive (loss) income before reclassifications 1,355 (1,136) 219 Reclassified gain from accumulated other comprehensive loss (1) — (2,541) (2,541) Tax effect — 23 23 Other comprehensive income (loss) after reclassifications 1,355 (3,654) (2,299) Ending balance at November 2, 2019 $ (110,106) $ 1,861 $ (108,245) Thirty-nine Weeks Ended November 2, 2019 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 2, 2019 $ (104,887) $ 2,435 $ (102,452) Other comprehensive (loss) income before reclassifications (5,219) 5,918 699 Reclassified gain from accumulated other comprehensive loss (1) — (6,845) (6,845) Tax effect — 353 353 Other comprehensive (loss) income after reclassifications (5,219) (574) (5,793) Ending balance at November 2, 2019 $ (110,106) $ 1,861 $ (108,245) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Segment Reporting

Segment Reporting	9 Months Ended
	Oct. 31, 2020
Segment Reporting [Abstract]
SEGMENT REPORTING	The Company’s two operating segments are brand-based: Hollister and Abercrombie, the latter of which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, operate in the same regulatory environments, and have been aggregated into one reportable segment. Amounts shown below include net sales from wholesale, franchise and licensing operations, which are not a significant component of total revenue, and are aggregated within their respective operating segment and geographic area. The Company’s net sales by operating segment for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Hollister $ 476,665 $ 514,772 $ 1,178,925 $ 1,447,975 Abercrombie 342,988 348,700 824,415 990,547 Total $ 819,653 $ 863,472 $ 2,003,340 $ 2,438,522 Net sales by geographic area are presented by attributing revenues to an individual country on the basis of the country in which the merchandise was sold for in-store purchases and on the basis of the shipping location provided by customers for digital orders. The Company’s net sales by geographic area for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 U.S. $ 557,814 $ 583,593 $ 1,339,347 $ 1,596,723 EMEA 190,214 191,977 474,165 566,563 APAC 43,618 55,910 117,768 188,836 Other 28,007 31,992 72,060 86,400 International $ 261,839 $ 279,879 $ 663,993 $ 841,799 Total $ 819,653 $ 863,472 $ 2,003,340 $ 2,438,522

Flagship Store Exit (Benefits)

Flagship Store Exit (Benefits) Charges (Notes)	9 Months Ended
	Oct. 31, 2020
Flagship Store Exit Charges [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Reflecting a continued focus on one of the Company’s key transformation initiatives ‘Global Store Network Optimization,’ the Company continues to pivot away from its large format flagship stores and strives to open smaller, more productive omnichannel focused brand experiences. As a result, the Company has closed certain of its flagship stores and may have additional closures as it executes against this strategy. As part of this ongoing effort, the Company recently announced the early exit of four European Abercrombie & Fitch flagship locations. Three of the leases will be transferred through assignment while the fourth lease will be subleased to a new tenant. The Company no longer has lease obligations beyond Fiscal 2020 for the three transfers and is scheduled to receive payments to fully offset its lease obligations on the sublease. Refer to Note 8, “ LEASES ,” for additional information on the sublease arrangement. Future fixed lease payments associated with closed flagship stores are reflected within short-term and long-term operating lease liabilities on the Condensed Consolidated Balance Sheets. Future fixed lease payments associated with flagship stores that were closed as of October 31, 2020, excluding the subleased flagship store, are scheduled to be paid through the fiscal year ending January 30, 2029 (“Fiscal 2028”) and are not expected to exceed $15 million in aggregate in any fiscal year. The Company recognizes impacts related to the exit of its flagship stores in flagship store exit (benefits) charges on the Consolidated Statements of Operations and Comprehensive Income (Loss). Details of the (benefits) charges incurred during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 related to this initiative follow: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Operating lease cost (1,729) — (6,959) 46,716 Gain on lease assignment (5,237) — (5,237) — Asset disposals and other store-closure costs (1) (405) — (3,610) (1,687) Employee severance and other employee transition costs (692) 285 3,316 1,994 Total flagship store exit (benefits) charges $ (8,063) $ 285 $ (12,490) $ 47,023 (1) Amounts represent costs incurred or benefits associated with returning the store to its original condition, including updated estimates to previously established accruals for asset retirement obligations and costs to remove inventory and store assets. As the Company continues its ‘Global Store Network Optimization’ efforts, it may incur future cash expenditures or incremental charges or realize benefits not currently contemplated due to events that may occur as a result of, or that are associated with, previously announced flagship store closures and flagship store closures that have not yet been finalized. At this time, the Company is not able to quantify the amount of future impacts, including any cash expenditures that may take place in future periods resulting from any potential flagship store closures given the unpredictable nature of lease exit negotiations and ultimate lease renewal decisions.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies Principles of Consolidation (Policies)	9 Months Ended
	Oct. 31, 2020
Basis of Presentation [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with MAF’s portion of net income presented as net income attributable to noncontrolling interests (“NCI”) on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and MAF’s portion of equity presented as NCI on the Condensed Consolidated Balance Sheets.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Fiscal Years (Policies)	9 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period, Policy [Policy Text Block]	Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended Number of weeks Fiscal 2019 February 1, 2020 52 Fiscal 2020 January 30, 2021 52

Summary of Significant Accoun_4

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Tables)	9 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements.

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Tables)	9 Months Ended
	Oct. 31, 2020
Condensed Statements of Cash Flows reconciliation [Abstract]
Reconciliation of Cash and Equivalents to Restricted cash and Equivalents [Table Text Block]	Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location October 31, 2020 February 1, 2020 November 2, 2019 February 2, 2019 Cash and equivalents Cash and equivalents $ 812,881 $ 671,267 $ 410,775 $ 723,135 Long-term restricted cash and equivalents Other assets 14,633 18,696 18,698 22,694 Short-term restricted cash and equivalents Other current assets 4,294 2,301 2,550 — Cash and equivalents and restricted cash and equivalents $ 831,808 $ 692,264 $ 432,023 $ 745,829

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Oct. 31, 2020
Revenue Recognition [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	The following table details certain contract liabilities representing unearned revenue as of October 31, 2020, February 1, 2020, November 2, 2019 and February 2, 2019: (in thousands) October 31, 2020 February 1, 2020 November 2, 2019 February 2, 2019 Gift card liability $ 22,910 $ 28,844 $ 19,855 $ 26,062 Loyalty program liability $ 19,640 $ 23,051 $ 21,396 $ 19,904 The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Revenue associated with gift card redemptions and gift card breakage $ 11,717 $ 12,653 $ 32,792 $ 40,729 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs $ 9,686 $ 9,249 $ 23,377 $ 23,795

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Table)	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	Additional information pertaining to net income (loss) per share attributable to A&F follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (40,742) (40,201) (40,759) (38,368) Weighted-average — basic shares 62,558 63,099 62,541 64,932 Dilutive effect of share-based compensation awards 1,319 812 — — Weighted-average — diluted shares 63,877 63,911 62,541 64,932 Anti-dilutive shares (1) 1,828 2,912 1,988 1,572 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The three levels of the hierarchy and the distribution of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of October 31, 2020 and February 1, 2020 were as follows: Assets at Fair Value as of October 31, 2020 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 68,271 $ 43,596 $ — $ 111,867 Derivative instruments (2) — 461 — 461 Rabbi Trust assets (3) 1 60,418 — 60,419 Restricted cash equivalents (4) 6,670 7,918 — 14,588 Total assets $ 74,942 $ 112,393 $ — $ 187,335 Liabilities: Derivative instruments (2) $ — $ 367 $ — $ 367 Total liabilities $ — $ 367 $ — $ 367 Assets and Liabilities at Fair Value as of February 1, 2020 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 225 $ 58,447 $ — $ 58,672 Derivative instruments (2) — 1,969 — 1,969 Rabbi Trust assets (3) 1 109,048 — 109,049 Restricted cash equivalents (4) 9,765 4,601 — 14,366 Total assets $ 9,991 $ 174,065 $ — $ 184,056 Liabilities: Derivative instruments (2) $ — $ 1,460 $ — $ 1,460 Total liabilities $ — $ 1,460 $ — $ 1,460 (1) Level 1 assets consist of investments in money market funds. Level 2 assets consist of time deposits. (2) Level 2 assets and liabilities consist primarily of foreign currency exchange forward contracts. (3) Level 1 assets consist of investments in money market funds. Level 2 assets consist of trust-owned life insurance policies. (4) Level 1 assets consist of investments in U.S. treasury bills and money market funds. Level 2 assets consist of time deposits.
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The carrying amount and fair value of the Company’s long-term gross borrowings were as follows: (in thousands) October 31, 2020 February 1, 2020 Gross borrowings outstanding, carrying amount $ 350,000 $ 233,250 Gross borrowings outstanding, fair value $ 374,063 $ 233,979

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net consisted of: (in thousands) October 31, 2020 February 1, 2020 Property and equipment, at cost $ 2,741,167 $ 2,744,967 Less: Accumulated depreciation and amortization (2,147,235) (2,079,677) Property and equipment, net $ 593,932 $ 665,290

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Single lease cost (1) $ 83,743 $ 104,726 $ 264,932 $ 318,270 Variable lease cost (2) 14,428 25,990 61,763 129,073 Operating lease right-of-use asset impairment (3) 3,979 9,047 44,397 12,636 Total operating lease cost $ 102,150 $ 139,763 $ 371,092 $ 459,979 (1) Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as rent abatements related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. (3) Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges.

Asset Impairment (Tables)

Asset Impairment (Tables)	9 Months Ended
	Oct. 31, 2020
Asset Impairment [Abstract]
Asset Impairment Charges [Text Block]	e thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Operating lease right-of-use asset impairment (1) $ 3,979 $ 9,047 $ 44,397 $ 12,636 Property and equipment asset impairment 2,350 3,563 12,943 5,580 Total asset impairment $ 6,329 $ 12,610 $ 57,340 $ 18,216 (1) Includes $3.2 million of operating lease right-of-use asset impairment related to flagship store exit charges for each of the thirteen and thirty-nine weeks ended November 2, 2019. Refer to Note 17, “ FLAGSHIP STORE EXIT (BENEFITS) CHARGES .” Asset impairment charges for the thirteen and thirty-nine weeks ended October 31, 2020 were principally the result of the impact of COVID-19 and were related to certain of the Company’s stores across brands, geographies and store formats. The impairment charges for the thirty-nine weeks ended October 31, 2020 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $102.2 million, including $94.2 million related to operating lease right-of-use assets. Asset impairment charges for the thirteen weeks and thirty-nine weeks ended November 2, 2019, primarily related to certain of the Company’s international flagship stores. The impairment charges for the thirty-nine weeks ended November 2, 2019 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $36.8 million, including $32.3 million related to operating lease right-of-use assets.

Rabbi Trust Assets (Tables)

Rabbi Trust Assets (Tables)	9 Months Ended
	Oct. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Components of Rabbi Trust Assets [Table Text Block]	Investments of Rabbi Trust assets consisted of the following as of October 31, 2020 and February 1, 2020: (in thousands) October 31, 2020 February 1, 2020 Trust-owned life insurance policies (at cash surrender value) $ 60,418 $ 109,048 Money market funds 1 1 Rabbi Trust assets $ 60,419 $ 109,049 Realized gains resulting from the change in cash surrender value of the Rabbi Trust assets for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Realized gains related to Rabbi Trust assets $ 391 $ 805 $ 1,369 $ 2,394

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Schedule of Borrowings	Details on the Company’s long-term borrowings, net, as of October 31, 2020 and February 1, 2020 are as follows: (in thousands) October 31, 2020 February 1, 2020 Long-term portion of borrowings, gross at carrying amount $ 350,000 $ 233,250 Unamortized fees (6,441) (932) Unamortized discount — (355) Long-term borrowings, net $ 343,559 $ 231,963

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	The following table details share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Share-based compensation expense $ 4,669 $ 5,796 $ 13,575 $ 8,464 Income tax benefit associated with share-based compensation expense recognized (1) $ — $ 1,211 $ — $ 1,566
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]	The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Income tax discrete benefits realized for tax deductions related to the issuance of shares (1) $ — $ 6 $ — $ 1,175 Income tax discrete charges realized upon cancellation of stock appreciation rights (1) — (447) — (611) Total income tax discrete (charges) benefits related to share-based compensation awards $ — $ (441) $ — $ 564
Schedule of Restricted Stock Unit Activity	The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 31, 2020: Service-based Restricted Performance-based Restricted Market-based Restricted Number of (1) Weighted- Number of Weighted- Number of Weighted- Unvested at February 1, 2020 1,676,831 $ 18.68 747,056 $ 15.11 421,784 $ 23.05 Granted 2,280,194 8.57 — — 519,905 16.24 Adjustments for performance achievement — — 38,381 11.37 134,122 11.79 Vested (790,429) 17.42 (481,304) 9.63 (350,447) 11.79 Forfeited (107,795) 13.83 (6,917) 22.80 (3,485) 35.61 Unvested at October 31, 2020 (2) 3,058,801 $ 11.63 297,216 $ 22.43 721,879 $ 21.46 (1) Includes 66,624 unvested restricted stock units as of October 31, 2020, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year. (2) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Certain unvested shares related to restricted stock units with performance-based vesting conditions can be achieved at up to 200% of their target vesting amount.
Schedule of Stock Appreciation Rights Activity	The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 31, 2020: Number of Weighted-Average Aggregate Weighted-Average Outstanding at February 1, 2020 796,725 $ 40.06 Granted — — Exercised — — Forfeited or expired (382,225) 47.87 Outstanding at August 1, 2020 414,500 $ 32.86 $ — 3.2 Stock appreciation rights exercisable at October 31, 2020 414,500 $ 32.86 $ — 3.2 Stock appreciation rights expected to become exercisable in the future as of October 31, 2020 — $ — $ — 0.0 No stock appreciation rights were exercised during the thirty-nine weeks ended October 31, 2020. Additional information pertaining to stock appreciation rights for the thirty-nine weeks ended November 2, 2019 follows: (in thousands) November 2, 2019 Total grant date fair value of awards exercised $ 620
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: (in thousands) October 31, 2020 November 2, 2019 Service-based restricted stock units: Total grant date fair value of awards granted $ 19,541 $ 16,175 Total grant date fair value of awards vested $ 13,769 $ 13,087 Performance-based restricted stock units: Total grant date fair value of awards granted $ — $ 5,379 Total grant date fair value of awards vested $ 4,635 $ — Market-based restricted stock units: Total grant date fair value of awards granted $ 8,443 $ 4,176 Total grant date fair value of awards vested $ 4,132 $ 511 The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 31, 2020 and November 2, 2019, respectively, were as follows: October 31, 2020 November 2, 2019 Grant date market price $ 12.31 $ 25.34 Fair value $ 16.24 $ 36.24 Assumptions: Price volatility 67 % 57 % Expected term (years) 2.4 2.9 Risk-free interest rate 0.2 % 2.2 % Dividend yield — % 3.2 % Average volatility of peer companies 66.0 % 40.0 % Average correlation coefficient of peer companies 0.4967 0.2407

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Oct. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheet as of February 1, 2020 were as follows: (in thousands) Location October 31, 2020 February 1, 2020 Location October 31, 2020 February 1, 2020 Derivatives designated as cash flow hedging instruments Other current assets $ 461 $ 1,869 Accrued expenses $ 367 $ 1,377 Derivatives not designated as hedging instruments Other current assets — 100 Accrued expenses — 83 Total $ 461 $ 1,969 $ 367 $ 1,460
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Gain (loss) recognized in AOCL (1) $ 93 $ (1,136) $ 12,328 $ 5,918 Gain reclassified from AOCL into cost of sales, exclusive of depreciation and amortization (2) $ 5,327 $ 2,541 $ 11,104 $ 6,845 (1) Amount represents the change in fair value of derivative contracts. (2) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) over the next twelve months. Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 (Loss) gain recognized in other operating (income) loss, net $ — $ (1,023) $ 742 $ 157

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Oct. 31, 2020
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	For the thirteen and thirty-nine weeks ended October 31, 2020, the activity in AOCL was as follows: Thirteen Weeks Ended October 31, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 1, 2020 $ (106,632) $ 7,539 $ (99,093) Other comprehensive income before reclassifications 2,142 93 2,235 Reclassified gain from accumulated other comprehensive loss (1) — (5,327) (5,327) Other comprehensive income (loss) after reclassifications (2) 2,142 (5,234) (3,092) Ending balance at October 31, 2020 $ (104,490) $ 2,305 $ (102,185) Thirty-nine Weeks Ended October 31, 2020 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 1, 2020 $ (109,967) $ 1,081 $ (108,886) Other comprehensive income before reclassifications 5,477 12,328 17,805 Reclassified gain from accumulated other comprehensive loss (1) — (11,104) (11,104) Other comprehensive income after reclassifications (2) 5,477 1,224 6,701 Ending balance at October 31, 2020 $ (104,490) $ 2,305 $ (102,185) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). (2) No tax effect was recognized during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction. For the thirteen and thirty-nine weeks ended November 2, 2019, the activity in AOCL was as follows: Thirteen Weeks Ended November 2, 2019 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 3, 2019 $ (111,461) $ 5,515 $ (105,946) Other comprehensive (loss) income before reclassifications 1,355 (1,136) 219 Reclassified gain from accumulated other comprehensive loss (1) — (2,541) (2,541) Tax effect — 23 23 Other comprehensive income (loss) after reclassifications 1,355 (3,654) (2,299) Ending balance at November 2, 2019 $ (110,106) $ 1,861 $ (108,245) Thirty-nine Weeks Ended November 2, 2019 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 2, 2019 $ (104,887) $ 2,435 $ (102,452) Other comprehensive (loss) income before reclassifications (5,219) 5,918 699 Reclassified gain from accumulated other comprehensive loss (1) — (6,845) (6,845) Tax effect — 353 353 Other comprehensive (loss) income after reclassifications (5,219) (574) (5,793) Ending balance at November 2, 2019 $ (110,106) $ 1,861 $ (108,245) (1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Oct. 31, 2020
Segment Reporting [Abstract]
Revenue from External Customers by Operating Segment [Table Text Block]	for the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Hollister $ 476,665 $ 514,772 $ 1,178,925 $ 1,447,975 Abercrombie 342,988 348,700 824,415 990,547 Total $ 819,653 $ 863,472 $ 2,003,340 $ 2,438,522
Revenue from External Customers by Geographic Areas [Table Text Block]	Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 U.S. $ 557,814 $ 583,593 $ 1,339,347 $ 1,596,723 EMEA 190,214 191,977 474,165 566,563 APAC 43,618 55,910 117,768 188,836 Other 28,007 31,992 72,060 86,400 International $ 261,839 $ 279,879 $ 663,993 $ 841,799 Total $ 819,653 $ 863,472 $ 2,003,340 $ 2,438,522

Flagship Store Exit (Benefits_2

Flagship Store Exit (Benefits) Charges (Tables)	9 Months Ended
	Oct. 31, 2020
Restructuring Cost and Reserve [Line Items]
Flagship Store Exit Charges [Table Text Block]	etails of the (benefits) charges incurred during the thirteen and thirty-nine weeks ended October 31, 2020 and November 2, 2019 related to this initiative follow: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Operating lease cost (1,729) — (6,959) 46,716 Gain on lease assignment (5,237) — (5,237) — Asset disposals and other store-closure costs (1) (405) — (3,610) (1,687) Employee severance and other employee transition costs (692) 285 3,316 1,994 Total flagship store exit (benefits) charges $ (8,063) $ 285 $ (12,490) $ 47,023 (1) Amounts represent costs incurred or benefits associated with returning the store to its original condition, including updated estimates to previously established accruals for asset retirement obligations and costs to remove inventory and store assets.

Summary of Significant Accoun_6

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019	Feb. 02, 2019
Condensed Statements of Cash Flows reconciliation [Abstract]
Cash and equivalents	$ 812,881	$ 671,267	$ 410,775	$ 723,135
Restricted Cash and Cash Equivalents	14,633	18,696	18,698	22,694
Restricted Cash and Cash Equivalents, Current	4,294	2,301	2,550	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 831,808	$ 692,264	$ 432,023	$ 745,829

Summary of Significant Accoun_7

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Details)	9 Months Ended
	Oct. 31, 2020
Recent Accounting Pronouncements [Abstract]
Maximum Length Of Time Inventory Sales Hedged	12 months

Impact of COVID-19 (Details)

Impact of COVID-19 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Impact of COVID-19 [Abstract]
Liquidity	$ 1,158,000		$ 1,158,000		$ 913,800
Inventory Write-down	14,800
Government Payroll Subsidies in response to COVID-19 Benefit	2,800		14,700
Asset Impairment Charges		$ 12,610	57,340	$ 18,216
Asset impairment, exclusive of flagship store exit charges	$ 6,329	$ 12,610	57,340	14,987
Income Tax Expense Benefit Continuing Operations Discrete Items			77,400
Proceeds from Short-term Debt			210,000	0
Withdrawal from Rabbi Trust Assets			50,000	0
Proceeds from Notes Payable			$ 350,000	$ 0

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020	Feb. 02, 2019
Revenue Recognition [Abstract]
Revenue recognized from Gift Card Program	$ 11,717	$ 12,653	$ 32,792	$ 40,729
Revenue recognized from Customer Loyalty Program Liability	9,686	9,249	23,377	23,795
Gift Card Liability, Current	22,910	19,855	22,910	19,855	$ 28,844	$ 26,062
Customer Loyalty Program Liability, Current	$ 19,640	$ 21,396	$ 19,640	$ 21,396	$ 23,051	$ 19,904

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares shares in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of Common Stock issued		103,300	103,300	103,300	103,300
Weighted-average treasury shares		(40,742)	(40,201)	(40,759)	(38,368)
Weighted-average — basic shares		62,558	63,099	62,541	64,932
Dilutive effect of share-based compensation awards		1,319	812	0	0
Weighted-average — diluted shares		63,877	63,911	62,541	64,932
Anti-dilutive shares (1)	[1]	1,828	2,912	1,988	1,572
[1]	Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($) $ in Thousands	Oct. 31, 2020		Feb. 01, 2020
Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	$ 111,867	[1]	$ 58,672
Derivative instruments (2)	461		1,969
Restricted Investments, Noncurrent	60,419		109,049
Restricted Cash Equivalents, Noncurrent	14,588	[2]	14,366
Total assets	187,335		184,056
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	367		1,460
Total liabilities	367		1,460
Level 1 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	68,271	[1]	225
Derivative instruments (2)	0		0
Restricted Investments, Noncurrent	1		1
Restricted Cash Equivalents, Noncurrent	6,670	[2]	9,765
Total assets	74,942		9,991
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	0		0
Total liabilities	0		0
Level 2 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	43,596	[1]	58,447
Derivative instruments (2)	461		1,969
Restricted Investments, Noncurrent	60,418		109,048
Restricted Cash Equivalents, Noncurrent	7,918	[2]	4,601
Total assets	112,393		174,065
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	367		1,460
Total liabilities	367		1,460
Level 3 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	0	[1]	0
Derivative instruments (2)	0		0
Restricted Investments, Noncurrent	0		0
Restricted Cash Equivalents, Noncurrent	0	[2]	0
Total assets	0		0
Liabilities, Fair Value Disclosure [Abstract]
Derivative instruments (2)	0		0
Total liabilities	0		0
Term Loan Facility
Liabilities, Fair Value Disclosure [Abstract]
Gross borrowings outstanding, carrying amount			233,250
Gross borrowings outstanding, fair value			$ 233,979
Senior Notes [Member]
Liabilities, Fair Value Disclosure [Abstract]
Gross borrowings outstanding, carrying amount	350,000
Gross borrowings outstanding, fair value	$ 374,063
[1]	Level 1 assets consist of investments in money market funds. Level 2 assets consist of time deposits. (2) Level 2 assets and liabilities consist primarily of foreign currency exchange forward contracts.
[2]	Level 1 assets consist of investments in U.S. treasury bills and money market funds. Level 2 assets consist of time deposits.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Property, Plant and Equipment [Line Items]
Store asset impairment	$ 2,350	$ 3,563	$ 12,943	$ 5,580
Property and equipment, at cost	2,741,167		2,741,167		$ 2,744,967
Less: Accumulated depreciation and amortization	(2,147,235)		(2,147,235)		(2,079,677)
Property and equipment, net	593,932		593,932		$ 665,290
Asset Impairment Charges		12,610	57,340	18,216
Asset impairment, exclusive of flagship store exit charges	$ 6,329	$ 12,610	$ 57,340	$ 14,987

Leases (Details)

Leases (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Oct. 31, 2020		Nov. 02, 2019		Oct. 31, 2020		Nov. 02, 2019
Leases [Abstract]
Single lease cost	[1]	$ 83,743		$ 104,726		$ 264,932		$ 318,270
Variable lease cost		14,428	[2]	25,990	[2]	61,763	[2]	129,073
Operating lease right-of-use asset impairment	[3],[4]	3,979		9,047		44,397		12,636
Operating lease cost		102,150		$ 139,763		371,092		459,979
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability						(41,305)		293,281
Cash paid for operating lease liabilities						224,827		$ 311,275
LesseeOperatingLeaseLeasesNotYetCommencedLiability		3,300				3,300
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals		$ 29,000				$ 29,000
[1]	Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities.
[2]	Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as rent abatements related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract.
[3]	(1) Includes $3.2 million of operating lease right-of-use asset impairment related to flagship store exit charges for each of the thirteen and thirty-nine weeks ended November 2, 2019. Refer to Note 17, “ FLAGSHIP STORE EXIT (BENEFITS) CHARGES .”
[4]	Refer to Note 9, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges.

Asset Impairment (Details)

Asset Impairment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Operating Lease, Right-of-Use Asset	$ 955,781		$ 955,781		$ 1,230,954
Asset impairment, exclusive of flagship store exit charges	6,329	$ 12,610	57,340	$ 14,987
Fair Value, Recurring [Member]
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Store Assets, including property and equipment and operating lease right-of-use assets	102,200	36,800	102,200	36,800
Operating Lease, Right-of-Use Asset	$ 94,200	$ 32,300	$ 94,200	$ 32,300

Rabbi Trust Assets (Details)

Rabbi Trust Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Defined Benefit Plan, Plan Assets, Category [Line Items]
Proceeds from Life Insurance Policy	$ 391	$ 805	$ 1,369	$ 2,394
Withdrawal from Rabbi Trust Assets			50,000	$ 0
Fair Value, Recurring [Member]
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	60,419		60,419		$ 109,049
Fair Value, Recurring [Member] | Level 2
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	60,418		60,418		109,048
Fair Value, Recurring [Member] | Level 1
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	$ 1		$ 1		$ 1

Income Taxes (Details)

Income Taxes (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (35,600)
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	41,800
Income Tax Expense Benefit Continuing Operations Discrete Items	77,400
Pre-Tax Losses Without Tax Benefits Recognized	180,700
United States
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(10,600)
GERMANY
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(6,000)
SWITZERLAND
Valuation Allowance [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ (78,900)

Borrowings (Details)

Borrowings (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Long-Term Borrowings [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	8.75%
Line of Credit Facility, Remaining Borrowing Capacity	$ 383,700
Long-term Debt, Excluding Current Maturities	343,559		$ 231,963
Schedule of Future Payments of the Term Loan Facility
ABL Facility, covenant terms, minimum remaining borrowing capacity	345,200
Letters of Credit Outstanding, Amount	(800)
Repayments of Short-term Debt	$ 210,000	$ 0
Senior Notes [Member]
Long-Term Borrowings [Line Items]
Maturity date	Jul. 15, 2025
Gross borrowings outstanding, carrying amount	$ 350,000
Unamortized discount	(6,441)
Unamortized Debt Issuance Expense Fees Paid to Lenders	0
Term Loan Facility
Long-Term Borrowings [Line Items]
Maximum borrowing capacity	300,000
Gross borrowings outstanding, carrying amount			233,250
Unamortized discount			(355)
Unamortized Debt Issuance Expense Fees Paid to Lenders			(932)
Borrowings, net			$ 231,963
ABL Facility
Long-Term Borrowings [Line Items]
Maximum borrowing capacity	$ 400,000
Maturity date	Oct. 19, 2022

Borrowings Schedule of Short-te

Borrowings Schedule of Short-term borrowings (Details) $ in Millions	Oct. 31, 2020USD ($)
Short-term debt disclosure [Abstract]
Line of Credit Facility, Remaining Borrowing Capacity	$ 383.7

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	$ (150)	$ (181)	$ (5,566)	$ (6,619)
Payment, Tax Withholding, Share-based Payment Arrangement	150	181	5,566	6,619
Share-based compensation expense	4,669	5,796	13,575	8,464
Tax benefit recognized related to share-based compensation expense	0	1,211	0	1,566
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	0	6	0	1,175
Share-based Payment Arrangement, Cancellation of Option, Tax Charge	0	(447)	0	(611)
Share-based Payment Arrangement, Discrete Income Tax Benefit (Charge)	0	(441)	0	564
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total grant date fair value of awards vested				620
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	27,879		$ 27,879
Unrecognized compensation cost, weighted-average period of recognition			1 year 3 months 18 days
Total grant date fair value of awards granted			$ 19,541	16,175
Total grant date fair value of awards vested			13,769	13,087
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	0		$ 0
Unrecognized compensation cost, weighted-average period of recognition			0 years
Total grant date fair value of awards granted			$ 0	5,379
Total grant date fair value of awards vested			4,635	0
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	9,939		$ 9,939
Unrecognized compensation cost, weighted-average period of recognition			1 year 1 month 6 days
Total grant date fair value of awards granted			$ 8,443	4,176
Total grant date fair value of awards vested			4,132	511
Additional Paid-in Capital [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(436)	(509)	(22,053)	(13,862)
Share-based compensation expense	$ 4,669	$ 5,796	$ 13,575	$ 8,464

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Exercise of Option, Tax Benefit		$ 0	$ 6	$ 0	$ 1,175
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 1, 2020				796,725
Number of Underlying Shares, Granted				0
Number of Underlying Shares, Forfeited				(382,225)
Number of Underlying Shares, Ending Balance at August 1, 2020		414,500		414,500
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at February 1, 2020				$ 40.06
Weighted-Average Grant Date Fair Value, Granted				0
Weighted-Average Grant Date Fair Value, Forfeited				47.87
Weighted-Average Grant Date Fair Value, Ending Balance at August 1, 2020		$ 32.86		$ 32.86
Service-based restricted stock units with $1.00 net income requirement [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Ending Balance at August 1, 2020		66,624		66,624
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 27,879		$ 27,879
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 1, 2020				1,676,831
Number of Underlying Shares, Granted				2,280,194
Number of Underlying Shares, Adjustments for performance achievement				0
Number of Underlying Shares, Vested				(790,429)
Number of Underlying Shares, Forfeited				(107,795)
Number of Underlying Shares, Ending Balance at August 1, 2020	[1]	3,058,801		3,058,801
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at February 1, 2020				$ 18.68
Weighted-Average Grant Date Fair Value, Granted				8.57
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				0
Weighted-Average Grant Date Fair Value, Vested				17.42
Weighted-Average Grant Date Fair Value, Forfeited				13.83
Weighted-Average Grant Date Fair Value, Ending Balance at August 1, 2020		$ 11.63		$ 11.63
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 3 months 18 days
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 0		$ 0
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 1, 2020				747,056
Number of Underlying Shares, Granted				0
Number of Underlying Shares, Adjustments for performance achievement				38,381
Number of Underlying Shares, Vested				(481,304)
Number of Underlying Shares, Forfeited				(6,917)
Number of Underlying Shares, Ending Balance at August 1, 2020		297,216		297,216
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at February 1, 2020				$ 15.11
Weighted-Average Grant Date Fair Value, Granted				0
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				11.37
Weighted-Average Grant Date Fair Value, Vested				9.63
Weighted-Average Grant Date Fair Value, Forfeited				22.80
Weighted-Average Grant Date Fair Value, Ending Balance at August 1, 2020		$ 22.43		$ 22.43
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				0 years
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 9,939		$ 9,939
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 1, 2020				421,784
Number of Underlying Shares, Granted				519,905
Number of Underlying Shares, Adjustments for performance achievement				134,122
Number of Underlying Shares, Vested				(350,447)
Number of Underlying Shares, Forfeited				(3,485)
Number of Underlying Shares, Ending Balance at August 1, 2020		721,879		721,879
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at February 1, 2020				$ 23.05
Weighted-Average Grant Date Fair Value, Granted				16.24	$ 36.24
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				11.79
Weighted-Average Grant Date Fair Value, Vested				11.79
Weighted-Average Grant Date Fair Value, Forfeited				35.61
Weighted-Average Grant Date Fair Value, Ending Balance at August 1, 2020		$ 21.46		$ 21.46
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 1 month 6 days
[1]	(1) Includes 66,624 unvested restricted stock units as of October 31, 2020, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year. (2) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Certain unvested shares related to restricted stock units with performance-based vesting conditions can be achieved at up to 200% of their target vesting amount.

Share-Based Compensation (Res_2

Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - $ / shares	9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date	Oct. 31, 2020
Fair value (in dollars per share)	$ 0
City Area Code	(614)
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 12.31	$ 25.34
Fair value (in dollars per share)	$ 16.24	$ 36.24
Price volatility	67.00%	57.00%
Expected term (years)	2 years 4 months 24 days	2 years 10 months 24 days
Risk-free interest rate	0.20%	2.20%
Dividend yield	0.00%	3.20%
Average volatility of peer companies	66.00%	40.00%
Average correlation coefficient of peer companies	0.4967	0.2407

Share-Based Compensation (Stock

Share-Based Compensation (Stock Appreciation Rights Activity) (Details) - USD ($)	9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 1, 2020	796,725
Number of Underlying Shares, Granted	0
Number of Underlying Shares, Exercised	0
Number of Underlying Shares, Forfeited	(382,225)
Number of Underlying Shares, Ending Balance at August 1, 2020	414,500
Number of Underlying shares, Stock appreciation rights exercisable	414,500
Number of Underlying Shares, Stock appreciation rights expected to become exercisable	0
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at February 1, 2020	$ 40.06
Weighted-Average Exercise Price, Granted	0
Weighted-Average Exercise Price, Exercised	0
Weighted-Average Exercise Price, Forfeited or expired	47.87
Weighted-Average Grant Date Fair Value, Ending Balance at August 1, 2020	32.86
Weighted-Average Exercise Price, Stock appreciation rights exercisable	32.86
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable	$ 0
Aggregate Intrinsic Value, Outstanding	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable	0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	3 years 2 months 12 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	3 years 2 months 12 days
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	0 years
Stock Appreciation Rights
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value		$ 620,000

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) $ in Thousands	Oct. 31, 2020USD ($)
Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	$ 65,537
United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	29,603
Canada, Dollars
Derivative [Line Items]
Notional Amount	$ 11,239

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value	$ 461	$ 1,869
Foreign Currency Cash Flow Hedge Liability at Fair Value	367	1,377
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value	0	100
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value	0	83
Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	461	1,969
Accrued expenses	367	1,460
Level 2 | Fair Value, Recurring [Member]
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	461	1,969
Accrued expenses	$ 367	$ 1,460

Derivative Instruments (Deriv_2

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCL on Derivative Contracts (Effective Portion)	[1]	$ 93	$ (1,136)	$ 12,328	$ 5,918
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[2]	5,327	2,541	11,104	6,845
Gain/(Loss)		$ 0	$ (1,023)	$ 742	$ 157
[1]	mount represents the change in fair value of derivative contracts.
[2]	Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives, Gain Deferred in AOCL				$ 12,600
Foreign Currency Cash Flow Hedge Asset at Fair Value		$ 461		461		$ 1,869
Foreign Currency Cash Flow Hedge Liability at Fair Value		367		367		1,377
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value		0		0		100
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value		0		0		83
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net	[1]	5,327	$ 2,541	$ 11,104	$ 6,845
Length of time inventory sales hedged (in months)				12 months
Derivative Instruments, Gain (Loss) Recognized in AOCL, Effective Portion, Net	[2]	93	$ (1,136)	$ 12,328	$ 5,918
Euro Member Countries, Euro
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount		65,537		65,537
United Kingdom, Pounds
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount		29,603		29,603
Canada, Dollars
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount		11,239		11,239
Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		461		461		1,969
Accrued expenses		367		367		1,460
Level 2 | Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		461		461		1,969
Accrued expenses		$ 367		$ 367		$ 1,460
[1]	Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.
[2]	mount represents the change in fair value of derivative contracts.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 31, 2020		Nov. 02, 2019		Oct. 31, 2020		Nov. 02, 2019
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	$ (99,093)		$ (105,946)		$ (108,886)		$ (102,452)
Other comprehensive income before reclassifications	2,235		219		17,805		699
Reclassified gain from accumulated other comprehensive loss (1)	(5,327)	[1]	(2,541)	[2]	(11,104)	[1]	(6,845)	[2]
Tax effect			23				353
Other comprehensive income after reclassifications (2)	(3,092)	[3]	(2,299)		6,701	[3]	(5,793)
Ending balance at October 31, 2020	(102,185)		(108,245)		(102,185)		(108,245)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(106,632)		(111,461)		(109,967)		(104,887)
Other comprehensive income before reclassifications	2,142		1,355		5,477		(5,219)
Reclassified gain from accumulated other comprehensive loss (1)	0		0		0		0
Tax effect			0				0
Other comprehensive income after reclassifications (2)	2,142	[3]	1,355		5,477	[3]	(5,219)
Ending balance at October 31, 2020	(104,490)		(110,106)		(104,490)		(110,106)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	7,539		5,515		1,081		2,435
Other comprehensive income before reclassifications	93		(1,136)		12,328		5,918
Reclassified gain from accumulated other comprehensive loss (1)	(5,327)		(2,541)		(11,104)		(6,845)
Tax effect			23				353
Other comprehensive income after reclassifications (2)	(5,234)	[3]	(3,654)		1,224	[3]	(574)
Ending balance at October 31, 2020	$ 2,305		$ 1,861		$ 2,305		$ 1,861
[1]	Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
[2]	Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
[3]	No tax effect was recognized during the thirteen and thirty-nine weeks ended October 31, 2020 due to the U.S. being a loss jurisdiction.

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details)	3 Months Ended	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2020
Segment Reporting Information [Line Items]
Number of Operating Segments	2
Number of reportable segments		1

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Schedule of Revenue by Brand [Line Items]
Net sales	$ 819,653	$ 863,472	$ 2,003,340	$ 2,438,522
Hollister
Schedule of Revenue by Brand [Line Items]
Net sales	476,665	514,772	1,178,925	1,447,975
Abercrombie
Schedule of Revenue by Brand [Line Items]
Net sales	$ 342,988	$ 348,700	$ 824,415	$ 990,547

Segment Reporting (Sales by Geo

Segment Reporting (Sales by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Net sales	$ 819,653	$ 863,472	$ 2,003,340	$ 2,438,522
United States
Net sales	557,814	583,593	1,339,347	1,596,723
EMEA [Member]
Net sales	190,214	191,977	474,165	566,563
Asia Pacific [Member]
Net sales	43,618	55,910	117,768	188,836
Other
Net sales	28,007	31,992	72,060	86,400
International [Member]
Net sales	$ 261,839	$ 279,879	$ 663,993	$ 841,799

Flagship Store Exit (Benefits_3

Flagship Store Exit (Benefits) Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Flagship Store Exit Charges [Abstract]
Lease Cost from Flagship Store Exits	$ (1,729)	$ 0	$ (6,959)	$ 46,716
Gain (Loss) on Termination of Lease	(5,237)	0	(5,237)	0
Property, Plant and Equipment, Disposals	(405)	0	(3,610)	(1,687)
Severance Costs	(692)	285	3,316	1,994
Flagship store exit (benefits) charges	(8,063)	$ 285	(12,490)	$ 47,023
Maximum Annual Cash Payments	$ 15,000		$ 15,000